Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia

ClinicalTrials.gov ID: NCT00118066

Public ClinicalTrials.gov record NCT00118066. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 5:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Phase II Trial Of Calcitriol In Patients With Prostatic Intraepithelial Neoplasia

Study identification

NCT ID
NCT00118066
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Rutgers, The State University of New Jersey
Other
Enrollment
12 participants

Conditions and interventions

Interventions

  • calcitriol Dietary Supplement
  • observation Procedure

Dietary Supplement · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2004
Primary completion
May 31, 2011
Completion
Jul 31, 2011
Last update posted
May 26, 2015

2004 – 2011

United States locations

U.S. sites
5
U.S. states
1
U.S. cities
4
Facility City State ZIP Site status
Central Jersey Oncology Center, PA - East Brunswick East Brunswick New Jersey 08816
Carol G. Simon Cancer Center at Morristown Memorial Hospital Morristown New Jersey 07962
Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick New Jersey 08903
Saint Peter's University Hospital New Brunswick New Jersey 08903
Overlook Hospital Summit New Jersey 07901

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00118066, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 26, 2015 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00118066 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →